VEGFA and age-related macular degeneration: To validate the characteristics of HXMM, a retina injury cell model induced by H2O2 was designed to simulate the retinal injury process occurring in AMD and DR, and bevacizumab was used as a positive control, as a commonly used clinical anti-VEGF drug.